Back to SO SOFTBANK GROUP CORP.
ABCL
3 quarters
Position history for SOSOFTBANK GROUP CORP.'s holdings in ABCELLERA BIOLOGICS INC
Yes. SoftBank Group holds 345,161 shares of ABCL (Abcellera Biologics), worth $2.7M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. SoftBank Group has held ABCL since Q4 2025, across 3 quarterly 13F filings.
Current Value
$2.7M
Current Shares
345,161
Total Value Change
+$1.5M
Total Shares Change
0
Quarter-by-Quarter History